MDC Partnership Wins Pfizer's Xalatan

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

NEW YORK Pfizer has awarded its $5 million Xalatan account to Source/Chinnici, a partnership between MDC siblings Source Marketing and Chinnici Direct.

Source/Chinnici in New York will handle brand duties as well as acquisition and customer relationship marketing for Xalatan, a prescription medication that treats glaucoma. Source Marketing in Westport, Conn.,

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in